Best Anthracycline Topoisomerase Inhibitor for breast neoplasms
Top-rated pick: Idarubicin Hydrochloride — pharmaranks score 72/100, the highest of the 5 Anthracycline Topoisomerase Inhibitor drugs used for breast neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for breast neoplasms or the full Anthracycline Topoisomerase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 5 anthracycline topoisomerase inhibitor drugs we rate for breast neoplasms, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for breast neoplasms; the right choice depends on your situation, so confirm it with your prescriber.
How anthracycline topoisomerase inhibitor work
These chemotherapy drugs slip between the strands of a cancer cell's DNA and jam an enzyme called topoisomerase II that the cell needs to copy its DNA. This leaves the DNA broken and unrepairable, so the cancer cell stops dividing and dies.
Other drug classes for breast neoplasms
Top anthracycline topoisomerase inhibitor for breast neoplasms: 1. Idarubicin Hydrochloride · 2. Ellence · 3. Idamycin Pfs
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | No data | — | View → | |
| 2 | 64/100 | Prescription | Injectable | No data | — | View → | |
| 3 | 64/100 | Prescription | Solution | No data | — | View → | |
| 4 | Not yet rated | Prescription | Injectable | No data | — | View → | |
| 5 | Not yet rated | Prescription | Injectable | No data | — | View → |
Full ranking · 5 drugs
idarubicin hydrochloride
Boxed warningPrescriptionFDA-sourced
Idarubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
ellence
Boxed warningPrescriptionFDA-sourced
Ellence (Epirubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms.
Price varies
idamycin pfs
Boxed warningPrescriptionFDA-sourced
Idamycin Pfs (Idarubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
doxil (liposomal)
Boxed warningPrescriptionFDA-sourced
Doxil (Liposomal) (Doxorubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Urinary Bladder Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Hodgkin Disease.
Price varies
doxorubicin hydrochloride (liposomal)
Boxed warningPrescriptionFDA-sourced
Doxorubicin Hydrochloride (Liposomal) (Doxorubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Urinary Bladder Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Hodgkin Disease.
Price varies
Frequently asked
- What is the best anthracycline topoisomerase inhibitor for breast neoplasms?
- By our independent recall-safety rating — not an efficacy measure — idarubicin hydrochloride ranks highest among Anthracycline Topoisomerase Inhibitor drugs used for breast neoplasms. Always consult a professional.
- Which anthracycline topoisomerase inhibitor drugs treat breast neoplasms?
- pharmaranks lists 5 Anthracycline Topoisomerase Inhibitor products used for breast neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.